arrow
G

Gaetano La Manna

irccs azienda ospedliero-universitaria di bologna policlinico di sant'orsola
H指数:44
被引数:7,839

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Case Report: Kidney allograft recovery after conversion to belatacept-based immunosuppression in simultaneous heart–kidney transplantation

病例报告:在同时进行的心-肾移植中,转换为以贝拉cept为基础的免疫抑制治疗后肾脏移植物恢复

2026-11-100
OA
Autosomal dominant polycystic kidney disease in Italy

意大利的常染色体显性多囊肾病

2026-10-280
OAAI
PolyCore, a bimodal peritoneal dialysis solution based on xylitol, L-carnitine, and icodextrin: In vitro evidence of the peritoneal membrane protection, rationale, and design of the phase II pilot study EXCITE

基于木糖醇、L-肉碱和艾考糊精的双模态腹膜透析液PolyCore:体外证据显示其对腹膜膜的保护作用、原理及II期试点研究EXCITE的设计

2026-10-080
PRE
Preoperative Parathyroid Imaging in CKD-Related Secondary Hyperparathyroidism: A Systematic Review and Diagnostic Test Accuracy Network Meta-analysis

术前甲状旁腺成像在CKD相关性继发性甲状旁腺功能亢进中的应用:一项系统评价和诊断试验准确性网络Meta分析

2026-10-010
OAAI
A comparative real-world analysis of finerenone and steroidal mineralocorticoid receptor antagonists in patients with chronic kidney disease

比较非奈利酮与类固醇盐皮质激素受体拮抗剂在慢性肾脏病患者中的真实世界分析

2026-09-090
OA
Case Report: Reopening the anabolic window — romosozumab added to ongoing denosumab for severe osteoporosis in two kidney transplant recipients

病例报告:重新开放合成代谢窗口——罗莫佐单抗添加到持续使用地诺单抗治疗中,用于两名肾移植受者的重度骨质疏松症

2026-09-040
OA
Identification of palliative care needs and prognostic factors of survival for tailoring appropriate interventions in advanced oncological, renal, and pulmonary diseases: results from a prospective observational study in an Italian population

识别姑息治疗需求及生存预后因素,以针对晚期肿瘤、肾脏和肺部疾病进行适当干预:来自意大利人群前瞻性观察研究的结果

2026-08-050
OAAI
Fibroblast growth factor 23 and mortality, heart failure and cardiovascular events across the chronic kidney disease spectrum - A systematic review and meta-analysis

成纤维细胞生长因子23与慢性肾病谱中的死亡率、心力衰竭和心血管事件——一项系统评价和荟萃分析

2026-06-130
OAAI
Lifestyle intervention to reduce cardiovascular risk in kidney transplant recipients: the KT-LIFESTYLE multicentre randomized controlled trial

生活方式干预以降低肾移植受者的心血管风险:KT-LIFESTYLE多中心随机对照试验

2026-05-120
OA
Flow Control and Oxygenation of Preservation Solution in Circulatory Determined Death Donors Undergoing Abdominal Normothermic Regional Perfusion

循环死亡捐献者接受腹部常温区域灌注时保存液的流量控制与氧合

2026-05-010
OAAI
Intra-Individual Variability of Urinary EGF and Clusterin, and Effect of Frozen Storage on Stability: Results from UVALID

尿液EGF和clusterin的个体内变异性及冷冻储存对其稳定性的影响:UVALID研究的结果

2026-04-270
OA
Recommendations for Pre-Analytical Urine Sample Handling To Allow Optimal Assessment of Albuminuria and Proteinuria A consensus report of the USA NKF Albuminuria – Proteinuria Workshop

关于优化评估尿微量白蛋白和蛋白尿的尿液样本前处理建议——美国肾脏基金会尿微量白蛋白-蛋白尿研讨会的共识报告

2026-04-240
OA
Missing opportunity for nephroprotective therapy in non-dialysis CKD patients under stable nephrology care

非透析CKD患者在稳定肾病学护理下错失肾脏保护治疗的机会

2026-04-140
OAAI
Belamaf: is renal toxicity an overlooked side effect?

Belamaf:肾毒性是否是一种被忽视的副作用?

2026-03-100
PRE